Frontline brentuximab vedotin (BV) and CHP in patients (pts) with peripheral T-cell lymphoma (PTCL) with 10% CD30 expression: Primary analysis results from the phase 2 SGN35-032 study. Safety and ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...
Pediatric anaplastic large cell lymphoma (ALCL) is a rare but highly curable T-cell non-Hodgkin lymphoma, most often driven by anaplastic lymphoma kinase (ALK) translocations and marked by uniform ...
Researchers at Nano Life Science Institute (WPI-NanoLSI) and the Cancer Research Institute at Kanazawa University have uncovered how targeted lung cancer drugs alter the shape and behavior of a key ...
There is an urgent need for innovative therapeutic options that impact disease progression after failure with standard of care, ALK tyrosine kinase inhibitor therapies TRI-611 is an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results